Scranton Hematology-Oncology — Scranton, Pennsylvania

Scranton Hematology-Oncology is a clinical research site located in Scranton, Pennsylvania, United States 18510.

Crixeo Health Trust Score: 62/100 (FAIR). This profile has not yet been claimed by the site owner.

Scranton Hematology-Oncology has participated in 4 clinical trials.

Therapeutic areas: Colorectal Cancer, Breast Cancer.

Sponsors: Alliance for Clinical Trials in Oncology, Herbert Irving Comprehensive Cancer Center, Theradex.

Sponsor Feasibility Report

Trust Score: 62/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Scranton Hematology-Oncology?

Scranton Hematology-Oncology has a Crixeo Trust Score of 62/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Scranton Hematology-Oncology conducted?

Scranton Hematology-Oncology has 4 clinical trials on record. Their work covers Colorectal Cancer, Breast Cancer.

Is Scranton Hematology-Oncology accredited by Crixeo Health?

Scranton Hematology-Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Scranton Hematology-Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.